News Release 4-Sep-2024 Peer-Reviewed PublicationUniversity of Illinois Chicago A cellular link between obesity and atrial fibrillation — a heart condition that afflicts over 33 million people worldwide — presents a promising target for new therapies, researchers from the University of Illinois Chicago report. Obesity is among the leading causes of atrial fibrillation, an irregular heart...
Tag: <span>cardiology</span>
Post
Large trial suggests AI for heart scans may benefit decision making for less-experienced clinicians
September 2, 2024 by European Society of Cardiology Credit: MART PRODUCTION from PexelsA large randomized trial showed no significant differences to demonstrate that using artificial intelligence (AI) to aid clinical decision-making in assessing heart ultrasounds is as effective as current practice at identifying all-comers with suspected heart disease who may benefit from invasive investigation and...
Post
Single tablet with four BP-lowering drugs found more effective than taking three drugs in separate pills
September 2, 2024 by European Society of Cardiology Credit: Unsplash/CC0 Public DomainA single-pill combination of four BP-lowering medications was significantly more effective than a combination of three medications, according to late-breaking research presented in a Hot Line session August 31 at ESC Congress 2024. Explaining why new treatment strategies are needed for hypertension, Principal Investigator,...
Post
Evening vs. morning dosing of blood pressure medication: No differences seen
September 2, 2024 by European Society of Cardiology Credit: Unsplash/CC0 Public DomainIn two trials, one in frail elderly patients, evening administration of BP-lowering medications had no clinical benefits over morning administration, according to late-breaking research presented in a Hot Line session August 31 at ESC Congress 2024. Principal Investigator, Professor Scott Garrison from the University...
Post
Scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects
August 30, 2024 by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) Summary of main findings by CNIC researchers. Clonal hematopoiesis and the expansion of blood cells carrying certain acquired mutations represent a new cause of atherosclerosis and cardiovascular disease, not a consequence of it. The effects of some of these mutations can be attenuated...
Post
New clues on how the heart makes arteries
August 30, 2024 by Max Delbrück Center for Molecular Medicine A 3D image of an embryonic mouse heart. Endothelial cells vascularize the heart muscle walls (shown in green). This process establishes the coronary vasculature that nourishes the heart muscle. Credit: Max Delbrück CenterA team led by Dr. Elena Cano in the Integrative Vascular Biology Lab...
Post
Digital consultations found to improve the rate at which heart failure patients receive optimal medication
August 31, 2024 by Amsterdam University Medical Centers Credit: Unsplash/CC0 Public DomainPatients with heart failure, a condition affecting more than 60 million worldwide, are four times more likely to receive the optimal combination of medications after 12 weeks of digital consultations. Researchers from five Dutch hospitals, coordinated by Amsterdam UMC, found that the use of...
Post
Does low lipoprotein(a) increase the risk of diabetes? New research suggests it does not
August 29, 2024 by Polskie Towarzystwo Lipidologiczne (Polish Lipid Association) Credit: CC0 Public DomainNew research has shown that, contrary to some previous studies, low levels of lipoprotein (a)—a parcel of fats and protein in the blood—do not cause type 2 diabetes. The findings may alleviate concerns that drugs aimed at reducing lipoprotein (a) [known as...
Post
New cardiovascular risk tool could guide who needs medication for high blood pressure
August 13, 2024 by Laura Williamson, American Heart Association News Credit: Pixabay/CC0 Public Domain For years, the question of whether to take medication to lower high blood pressure had been partly answered by a tool that calculated someone’s 10-year risk of having a heart attack or stroke. But new equations, which take into account both...
Post
Research shows that smartwatch and clinical testing measures differ
August 26, 2024 by Linda Skidmore, West Virginia University New West Virginia University research finds heart rate variability—the time between heartbeats—reported on smartwatches and rings is different from what’s recorded in clinical settings. Credit: WVU Illustration/Aira BurkhartAt a time when usage of smartwatches and rings has become more common, a West Virginia University human performance...